Fc receptor blockade and immune thrombocytopenic purpura

Seminars in Hematology

Volumn 37, Issue 3, 2000, Pages 261-266

  Bussel, James B ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYTOKINE; FC RECEPTOR; IMMUNOGLOBULIN D; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY;

ARTICLE; CELL DESTRUCTION; CLINICAL TRIAL; CYTOKINE RELEASE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; PRIORITY JOURNAL; RECEPTOR BLOCKING; THROMBOCYTE COUNT;

EID: 0033864569     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0037-1963(00)90104-5     Document Type: Article

References (42)

1. Treatment of childhood idiopathic thrombocytopenic purpura with Rhesus antibodies (anti-D)
2. Inhibition of autoantibody binding to platelet glycoprotein IIb/IIIa by anti-idiotypic antibodies in intravenous gammaglobulin
3. Randomized trial of immunoglobulin G, intravenous anti-D and oral prednisone in acute immune thrombocytopenic purpura
4. Autoantibodies directed against different classes of Fc gamma R are found in sera of autoimmune patients
5. Anti-DIG for treatment of immune thrombocytopenic purpura
6. Mechanisms of intravenous immunoglobulin treatment in childhood acute idiopathic thrombocytopenic purpura. Comparison of F(ab)2 versus Fc containing IgG
7. Immune thrombocytopenic purpura, neonatal alloimmune thrombocytopenic and posttransfusion purpura
8. Anti-D IG for treatment of immune thrombocytopenic purpura
9. Intravenous anti-D treatment of immune thrombocytopenic purpura: Analysis of efficacy, toxicity, and mechanism of effect
10. The use and mechanism of action of intravenous immunoglobulin in the treatment of immune haematologic disease
11. Infusion of a monoclonal anti-FcR III in patients with refractory ITP
12. Intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpura
13. In patients with ITP, does 75 μg/kg of IV anti-D increase the platelet count faster than 50 μg/kg?
14. The role of complement and complement receptors in induction and regulation of immunity
15. Treatment of refractory immune thrombocytopenic purpura with an anti-Fc gamma-receptor antibody
16. Blockade of immune complex clearance by a monoclonal antibody
17. Infusion of Fc gamma fragments for treatment of children with acute immune thrombocytopenic purpura
18. Monoclonal antibody 197 (anti-Fc gamma RI) infusion in a patient with immune thrombocytopenia purpura (ITP) results in down-modulation of Fc gamma RI on circulating monocytes
19. Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gammaglobulin
20. Human neutrophil Fc receptor distribution and function
21. Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology
22. Treatment of chronic autoimmune thrombocytopenic purpura with monoclonal anti-D
23. Levels of anti-A and anti-B in commercial immuneglobulins
24. Phagocytosis of antibody-coated platelets by human granulocytes
25. Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura
26. Complement and Fc-receptors in regulation of the antibody response
27. High-dose intravenous gammaglobulin therapy of refractory, in particular idiopathic thrombocytopenia in childhood
28. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood
29. The concentration of IgG in the serum is a major determinant of Fc-dependent reticuloendothelial function
30. Modulation of mononuclear phagocyte function by intravenous gammaglobulin
31. + red blood cells and suppression of Rh D immunization in Rh D-volunteers
32. The effect of various steroids on the phagocytic activity of the reticuloendothelial system
33. Anti-RH immunoglobulin therapy for human immunodeficiency virus-related immune thrombocytopenic purpura
34. Fc receptors
35. Treatment of autoimmune thrombocytopenic purpura with Rhesus antibodies [anti-Rh0(D)]
36. Effect of IgG anti-Rho(D) in adult patients with chronic autoimmune thrombocytopenia
37. Effect of intravenous immunoglobulin in immune thrombocytopenia
38. The biology and the pathology of Fc receptors
39. Intravenous anti-D treatment of immune thrombocytopenic purpura: Experience in 272 patients
40. The role of the reticuloendothelial system in the pathogenesis of idiopathic thrombocytopenic purpura
41. Immunoglobulin G dimer: An idiotype-anti-idiotype complex
42. Fc-depleted vs. intact intravenous immunoglobulin in chronic ITP